In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

Galmed Pharmaceuticals Ltd.. Trade Record

NASDAQ:GLMD Galmed Pharmaceuticals Ltd. stock gains 6.23% Exit May 1, 2017 a Trade Record by priceseries

Trade Chart
Trade Chart GLMD Apr 27, 2017, priceSeries
About Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of a once-daily, oral therapy for the treatment of liver diseases. It is developing Aramchol, which is in ARREST study, a Phase IIb clinical study for the treatment of patients with overweight or obesity, and who are pre-diabetic or type-II-diabetic with non-alcoholic steato-hepatitis. The company was founded in 2000 and is headquartered in Tel Aviv, Israel.

Trade Information
Trade Type
Entry Date
Apr 27, 2017
Entry Price
Sell Date
May 1, 2017
Sell Price
Net Gain
Hold Time
2 Trading Days